SEC Form D · Amendment · filed May 24, 2017
Genoa Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Ketan W. Patel · Seattle, WADirectorTiba W. Aynechi · Seattle, WADirectorNiall W. O'Donnell · Seattle, WADirectorHeather W. Preston · Seattle, WADirectorMark W. Surber, Ph.D · Seattle, WAExecJohn Ajay · Palm Beach Gardens, FLDirectorRandall R. Kendrick · Dallas, TXDirectorCary Marr · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsDirectorJonathan W. Leff, M.D · Seattle, WADirectorBruce W. Montgomery, M.D · Seattle, WAExec · DirectorNaveed W. Siddiqi · Seattle, WADirectorGeoffrey Kowalski · Laguna Niguel, CADirectorBenjamin Swinford · Costa Mesa, CADirectorMichael Garland · Nashville, TNDirectorJonathan W. Leff, M.D · Seattle, WADirectorBruce W. Montgomery, M.D · Seattle, WAExec · DirectorNaveed W. Siddiqi · Seattle, WADirectorHeather W. Preston · Seattle, WADirectorMark W. Surber, Ph.D · San Diego, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗